Cantuzumab ravtansine | Read Reviews & Product Use Citations

Cantuzumab ravtansine (IMGN242, HUC242-DM4) is an ADC. It is a humanized monoclonal antibody, huC242, covalently linked via a disulfide bond to DM4 (DM4 (HY-12454)). Cantuzumab ravtansine has broad antitumor efficacy against a range of CanAg-positive human tumor xenografts.

CAS No. 868747-45-9

Purity & Quality Control

≥99

Biological Activity

Description	Cantuzumab ravtansine (IMGN242, HUC242-DM4) is an ADC. It is a humanized monoclonal antibody, huC242, covalently linked via a disulfide bond to DM4 (DM4 (HY-12454)). Cantuzumab ravtansine has broad antitumor efficacy against a range of CanAg-positive human tumor xenografts.

References
[1] Lutz RJ, et al. Cancer Res (2005) 65 (9_Supplement): 334–335. [2] Ab O, et al. Mol Cancer Ther (2007) 6 (11_Supplement): A127.

References

Product Details

CAS No.	868747-45-9
ADC antiody	Cantuzumab
ADC cytotoxin	DM4
Formulation	1xPBS
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field